Market Overview

Myomo to Report Second Quarter 2018 Results on August 7, 2018


Management to hold a conference call at 4:30 p.m. EDT

Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable
medical robotics company, today announced that it will release its
financial results for the second quarter 2018 on Tuesday, August 7,
2018, after the US markets close.

The Company will host a conference call on Tuesday, August 7, 2018 at
4:30 p.m. EDT featuring remarks by Paul R. Gudonis, Chairman and Chief
Executive Officer, and Ralph A. Goldwasser, Chief Financial Officer. The
conference call, webcast and accompanying slides can be accessed through
Myomo's Investor
page. Please allow extra time prior to the call to visit
the site and download any necessary software to listen to the live

To dial into the conference call, please dial 1-877-270-2148 from the
U.S. or 1-412-902-6510 internationally. Please instruct to be joined
into Myomo's earnings conference call. A replay of the conference call
will be available approximately one hour after completion of the live
conference call at the Investor
page. A dial-in replay of the call will be available until
August 21, 2018; please dial 1-877-344-7529 from the U.S. or
1-412-317-0088 internationally and provide the passcode of 10122822.

About Myomo
Myomo, Inc. is a wearable medical robotics
company that offers expanded mobility for those suffering from
neurological disorders and upper limb paralysis. Myomo develops and
markets the MyoPro product line. MyoPro is a powered upper limb orthosis
designed to restore function to the weakened or paralyzed arms of
patients suffering from CVA stroke, brachial plexus injury, traumatic
brain or spinal cord injury, ALS or other neuromuscular disease or
injury. It is currently the only marketed device that, sensing a
patient's own EMG signals through non-invasive sensors on the arm, can
restore an individual's ability to perform activities of daily living,
including feeding themselves, carrying objects and doing household
tasks. Many are able to return to work, live independently and reduce
their cost of care. Myomo is headquartered in Cambridge, Massachusetts,
with sales and clinical professionals across the U.S. For more
information, please visit

View Comments and Join the Discussion!